Dignaß A - Search Results

1

Exercise improves functional capacity and lean body mass in patients with gastrointestinal cancer during chemotherapy: a single-blind RCT.

Stuecher K, Bolling C, Vogt L, Niederer D, Schmidt K, Dignaß A, Banzer W. Stuecher K, et al. Among authors: dignass a. Support Care Cancer. 2019 Jun;27(6):2159-2169. doi: 10.1007/s00520-018-4478-5. Epub 2018 Oct 4. Support Care Cancer. 2019. PMID: 30288602 Clinical Trial.

2

Psychosocial distress in acute cancer patients assessed with an expert rating scale.

Senf B, Brandt H, Dignass A, Kleinschmidt R, Kaiser J. Senf B, et al. Among authors: dignass a. Support Care Cancer. 2010 Aug;18(8):957-65. doi: 10.1007/s00520-010-0850-9. Epub 2010 Apr 11. Support Care Cancer. 2010. PMID: 20383721 Free PMC article.

3

Correction to: Psychosocial distress in acute cancer patients assessed with an expert rating scale.

Senf B, Brandt H, Dignass A, Kleinschmidt R, Kaiser J. Senf B, et al. Among authors: dignass a. Support Care Cancer. 2020 May;28(5):2433. doi: 10.1007/s00520-020-05305-3. Support Care Cancer. 2020. PMID: 32103360 Free PMC article.

4

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials.

Rahbari NN, Biondo S, Frago R, Feißt M, Kreisler E, Rossion I, Serrano M, Jäger D, Lehmann M, Sommer F, Dignass A, Bolling C, Vogel I, Bork U, Büchler MW, Folprecht G, Kieser M, Lordick F, Weitz J; SYNCHRONOUS and CCRe-IV Trial Groups. Rahbari NN, et al. Among authors: dignass a. J Clin Oncol. 2024 May 1;42(13):1531-1541. doi: 10.1200/JCO.23.01540. Epub 2024 Feb 27. J Clin Oncol. 2024. PMID: 38412408 Clinical Trial.

5

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.

Schmidt KJ, Müller N, Dignass A, Baumgart DC, Lehnert H, Stange EF, Herrlinger KR, Fellermann K, Büning J. Schmidt KJ, et al. Among authors: dignass a. J Crohns Colitis. 2016 Jan;10(1):31-7. doi: 10.1093/ecco-jcc/jjv175. Epub 2015 Sep 28. J Crohns Colitis. 2016. PMID: 26419459

6

Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.

Probert CS, Dignass AU, Lindgren S, Oudkerk Pool M, Marteau P. Probert CS, et al. J Crohns Colitis. 2014 Mar;8(3):200-7. doi: 10.1016/j.crohns.2013.08.007. Epub 2013 Sep 4. J Crohns Colitis. 2014. PMID: 24012063 Clinical Trial.

7

Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease.

Seeger WA, Thieringer J, Esters P, Allmendinger B, Stein J, Schulze H, Dignass A. Seeger WA, et al. Among authors: dignass a. United European Gastroenterol J. 2020 Aug;8(7):804-813. doi: 10.1177/2050640620936383. Epub 2020 Jun 25. United European Gastroenterol J. 2020. PMID: 32580666 Free PMC article. Clinical Trial.

8

Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis.

Dignass AU, Eriksson A, Kilander A, Pukitis A, Rhodes JM, Vavricka S. Dignass AU, et al. Aliment Pharmacol Ther. 2010 Jun;31(12):1286-95. doi: 10.1111/j.1365-2036.2010.04295.x. Epub 2010 Mar 11. Aliment Pharmacol Ther. 2010. PMID: 20331579 Free article. Clinical Trial.

9

Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.

Dignass A, Stoynov S, Dorofeyev AE, Grigorieva GA, Tomsová E, Altorjay I, Tuculanu D, Bunganič I, Pokrotnieks J, Kupčinskas L, Dilger K, Greinwald R, Mueller R; International Budenofalk Study Group. Dignass A, et al. J Crohns Colitis. 2014 Sep;8(9):970-80. doi: 10.1016/j.crohns.2014.01.021. Epub 2014 Feb 15. J Crohns Colitis. 2014. PMID: 24534142 Clinical Trial.

10

A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients.

Schulze H, Esters P, Hartmann F, Stein J, Christ C, Zorn M, Dignass A. Schulze H, et al. Among authors: dignass a. Scand J Gastroenterol. 2018 Jun;53(6):670-676. doi: 10.1080/00365521.2018.1452974. Epub 2018 Mar 21. Scand J Gastroenterol. 2018. PMID: 29560811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page